Showing results (41-50 of 66) with videos related to
Sort By:
Pageof 7
Journal of Cancer|August 19, 2017
MDM2 SNP309 and SNP285 Act as Negative Prognostic Markers for Non-small Cell Lung Cancer Adenocarcinoma PatientsChristophe Deben, Ken Op de Beeck, Jolien Van den Bossche, et al.Cancer Letters|March 16, 2016
APR-246 (PRIMA-1(MET)) strongly synergizes with AZD2281 (olaparib) induced PARP inhibition to induce apoptosis in non-small cell lung cancer cell linesChristophe Deben, Filip Lardon, An Wouters, et al.Plos One|January 7, 2017
Long-Term Depletion of Conventional Dendritic Cells Cannot Be Maintained in an Atherosclerotic Zbtb46-DTR Mouse ModelMiche Rombouts, Nathalie Cools, Mandy O J Grootaert, et al.Oncotarget|July 1, 2015
The MDM2-inhibitor Nutlin-3 synergizes with cisplatin to induce p53 dependent tumor cell apoptosis in non-small cell lung cancerChristophe Deben, An Wouters, Ken Op de Beeck, et al.Cancers|December 5, 2019
Radiosensitization of Non-Small Cell Lung Cancer Cells by the Plk1 Inhibitor Volasertib Is Dependent on the p53 StatusJolien Van den Bossche, Andreas Domen, Marc Peeters, et al.Molecular Oncology|March 13, 2019
In vitro study of the Polo-like kinase 1 inhibitor volasertib in non-small-cell lung cancer reveals a role for the tumor suppressor p53Jolien Van den Bossche, Christophe Deben, Ines De Pauw, et al.Cancer Letters|September 7, 2014
Overcoming cetuximab resistance in HNSCC: the role of AURKB and DUSP proteinsCarolien Boeckx, Ken Op de Beeck, An Wouters, et al.Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 30, 2026
FLASH radiotherapy induces unique immunotranscriptomic profiles compared to conventional dose-rate radiotherapy, despite identical immune infiltration and antitumor efficacy in a murine model of triple-negative breast cancerAdrien Arrigo, Louize Brants, Laura Kramp, et al.Journal of Agricultural and Food Chemistry|February 3, 2016
Reducing Compounds Equivocally Influence Oxidation during Digestion of a High-Fat Beef Product, which Promotes Cytotoxicity in Colorectal Carcinoma Cell LinesThomas Van Hecke, An Wouters, Caroline Rombouts, et al.Seminars in Cancer Biology|October 13, 2019
The potential and controversy of targeting STAT family members in cancerYannick Verhoeven, Sam Tilborghs, Julie Jacobs, et al.Pageof 7